Pub. Date : 2022
PMID : 35126877
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Using doxorubicin (Dox) as a model chemotherapeutic drug, the Ca2+ nano-inhibitors efficiently deprived intracellular excessive free Ca2+, suppressed P-glycoprotein (P-gp) expression and significantly enhanced intracellular drug accumulation in Dox-resistant tumor cells. | Doxorubicin | ATP binding cassette subfamily B member 1 | Homo sapiens |
2 | Using doxorubicin (Dox) as a model chemotherapeutic drug, the Ca2+ nano-inhibitors efficiently deprived intracellular excessive free Ca2+, suppressed P-glycoprotein (P-gp) expression and significantly enhanced intracellular drug accumulation in Dox-resistant tumor cells. | Doxorubicin | ATP binding cassette subfamily B member 1 | Homo sapiens |
3 | Using doxorubicin (Dox) as a model chemotherapeutic drug, the Ca2+ nano-inhibitors efficiently deprived intracellular excessive free Ca2+, suppressed P-glycoprotein (P-gp) expression and significantly enhanced intracellular drug accumulation in Dox-resistant tumor cells. | Doxorubicin | ATP binding cassette subfamily B member 1 | Homo sapiens |
4 | Using doxorubicin (Dox) as a model chemotherapeutic drug, the Ca2+ nano-inhibitors efficiently deprived intracellular excessive free Ca2+, suppressed P-glycoprotein (P-gp) expression and significantly enhanced intracellular drug accumulation in Dox-resistant tumor cells. | Doxorubicin | ATP binding cassette subfamily B member 1 | Homo sapiens |